TH76798B - Healing accelerator of living bodies - Google Patents

Abstract

DC60 (06/16/16) This invention provides the wound healing effect of living organisms, which has the effect of accelerating the Replacement growth involved in the treatment of cell damage. or tissue caused by toxicity of medicines or wounds in living organisms, which is very safe, and does not cause any side effects Also, even after using it for a long time, many problems can be solved by the body's healing accelerator. Organisms containing mixtures of culture solutions prepared after inoculation of microorganisms classified as Aureobasidium sp. and mycelium of microorganisms cultured in this culture solution are active ingredients. The body's healing accelerator according to this invention should be used. For reducing the side effects of anticancer drugs, preferably used for speeding wound healing, and additionally, preferably for accelerating blood glucose normalization and for relief. Pathological condition of leukemia Invention Summary Edit 16/06/2016 This invention provides healing for the living body, which has the effect of accelerating the ability to Replacement growth involves healing cell damage. or tissue caused by toxicity of drugs or wounds in living organisms, which are highly safe, and do not cause any side effects Also, even if given for a long time, problems can be solved by the body's healing accelerator. Organisms containing mixtures of culture solutions prepared after inoculation of microorganisms classified as Aureobasidium sp. and mycelium of microorganisms cultured in this culture solution are active ingredients. The body's healing accelerator according to this invention should be used. For reducing side effects of anticancer drugs, preferably used for speeding wound healing, and additionally, preferably for accelerating blood glucose normalization and for relief. Pathological condition of leukemia ---------------------------------------------------- ------------------ This invention provides the wound healing effect of living organisms, which has the effect of accelerating the Replacement proliferation involves the treatment of cellular or tissue damage caused by toxicity. of medicines or wounds in living organisms, which is very safe, and does not cause any side effects Also, even after using it for a long time, many problems were solved with the Body's Healing Accelerator. An organism containing a mixture of culture solutions prepared after inoculation of microorganisms classified as Aureobasidium sp. and mycotoxins of microorganisms cultured in this culture solution is the active ingredient. The body's wound healing accelerator according to this invention should be It is used to reduce the side effects of anticancer drugs, preferably used for accelerated wound healing of blind wounds, and additionally, preferably used for accelerating blood glucose levels. normal and for alleviating pathological conditions of leukemia, patent medicine

Claims (6)

Disclaimer (all) which will not appear on the advertisement page: EDIT 16/06/2016 1. Healing accelerator (healing) of the body of living beings which consists of a mixture of The inoculation solution obtained after cultivation believed the microorganisms in them. Aureobasidium s p. And mycelium of microorganisms cultured in the culture solution are active ingredients, for use in the body in Healing damage to tissues caused by anticancer drug toxicity. 5-fluoroyuracil (5-FU) 2. Healing accelerator of the body of organisms according to claim 1, where microorganisms in them Aureobasidium sp is Aureobasidium pullulans strain M-1, (Deposited number of FERM BP- 08615 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) or Aureobasidium pullulans strain M-2, (Deposited number of FERM BP- 10014 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) 3. The use of mixtures of inoculated solutions obtained after culturing microorganisms in their class. Aureobasidium sp and mycelium of microorganisms cultured in culture solution in drug production for Healing damage to tissues caused by anticancer drug toxicity. 5-fluoroyuracil (5-FU) 4. Use according to claim 3, where the microorganisms in them Aureobasidium s p. Is Aureobasidium pullulans strain M-1, (Deposited number of FERM BP-08615 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) or Aureobasidium pullulans strain M-2, (Deposited number of FERM BP- 10014 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) 5. Healing catalyst of living organisms, which consists of mixtures of cultured solutions. The germs obtained after culture of Aureobasidium pullulans and mycelium of cultured microorganisms. In culture solution as an active ingredient, for use as a therapeutic agent. Healing of Wounds 6. Accelerator of healing of the body of the organism according to claim 5, where the wound is made. In conjunction with surgery Or from a burn on the skin, and the body's healing catalyst will be It is applied directly to the affected area 7. Healing accelerator of the organism in accordance with claim 5, or 6, where Aureobasidium pullulans is Aureobasidium pullulans strain M-1, (Deposited with number FERM BP-08615 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) or Aureobasidium pullulans strain M-2, (Deposited with number FERM BP- 10014 at Intermational Patent Organism Depositary, National Institute. of Advanced Industrial Science and Techology (Independent Administrative Corporation)) 8. The use of mixtures of inoculum solution obtained after culture of Aureobasidium pullulans and mycelium of microorganisms cultured in culture solution in drug production for use. About healing in stimulating the healing of the body of the organism, where the drug is for stimulation. Wound healing 9. Use of claim No. 8, where the wound was co-ordinated with surgery. Or from burns on the skin, and the drug is applied directly to the affected area 1 0. Use in accordance with Clause 8 or 9, where Aureobasidium pullulans is Aureobasidium pullulans strain M-1, (Deposited with number FERM BP-08615 at Intermational Patent Organism Depositary, National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) or Aureobasidium pullulans strain M-2, (Deposited with number FERM BP- 10014 at Intermational Patent Organism Depositary. , National Institute of Advanced Industrial Science and Techology (Independent Administrative Corporation)) ----------------------------------- ------------ 1. Healing accelerator of the organism, which consists of a mixture of solutions. After culturing the microorganisms that were classified in the group. Aureobasidium s p. And mycelium group of microorganisms cultured in this culture solution. As an active component 2. Accelerator for wound healing of living organisms according to claim 1, which accelerates wound healing This organism has been used for reducing the side effects of anti-cancer drugs. 3. The body's wound healing accelerator according to claim 2, which this anticancer drug is 5-Fluoroyuracil (5-FU) 4. Healing accelerator of the organism, according to claim 1, which accelerates wound healing. The body of this organism is used for accelerating wound healing. 5. The wound healing accelerator of the living body according to claim 4, in which this wound occurs. In conjunction with surgery or from burns on the skin, and the body's wound healing accelerator, this organism Will be given directly to the affected area. 6. The accelerator wound healing of the organism according to claim 1, which the accelerator wound healing. This organism is used for accelerating the normalization of blood glucose levels. 7. Healing accelerator of the organism according to claim 1, which accelerates wound healing. This organism has been used to improve the pathological condition of leukemia. 8. The wound healing accelerator of the organism according to one of the claims 1 to 7, which contains the microorganisms classified. In class Aureobasidium s p. Is Aureobasidium pulluluns M-1 (Deposited number of FERM BP-08615 at International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (Independent Administrative Corporation)) or Aureobasidium pulluluns strain M-2. (Deposited number of FERM BP-10014 at International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (Independent Administrative Corporation)) 9. Use of mixtures of culture solution prepared after Microbial culture Belonging to Aureobasidium s p. And mycelium group of microorganisms cultured in the culture solution. In the manufacture of drugs to accelerate wound healing of living organisms 1 0. Use according to claim 9, where this drug is used to reduce the side effects of anticancer drugs 1 1. Use according to claim 10, which this anticancer drug is 5- Fluoroyuracil (5-FU) 1 2. Use according to claim 9, for which this drug is used to accelerate wound healing 1. 3. Use according to claim 12, where this wound occurs in conjunction with surgery or from a skin burn, and the drug is to be used directly on the affected area 1 4.Use according to claim 9, which the drug is used to accelerate the normalization of blood glucose levels 1 5. Use according to claim 9, for which this drug is used to improve the pathology of leukemia 1. 6. Use in accordance with any of Clause 9 to 15, in which microorganisms classified as Aureobasidium s p. Is Aureobasidium pulluluns M-1 (Deposited number of FERM BP-08615 at International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (Independent Administrative Corporation)) or Aureobasidium pulluluns strain M-2. (Deposited number of FERM BP-10014 at International Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology (Independent Administrative Corporation))